In 2024, genetic analysis using a next-generation sequencing (NGS) panel specific to skeletal dysplasias identified a homozygous variant in TMEM38B (NM_018112.3:c.112 + 1G > T), classified as likely pathogenic and consistent with autosomal recessive OI Type XIV. This evidence concerns the gene TMEM38B and skeletal dysplasia.